News

The US Food and Drug Administration (FDA) has approved the label expansion of AbbVie’s Mavyret (glecaprevir/pibrentasvir) for ...
The FDA expanded the approval of the direct-acting antiviral (DAA) glecaprevir/pibrentasvir (Mavyret), making it the first ...
ASPPH proudly joined public health and medical leaders for a Congressional Briefing on the Hepatitis C Elimination Imperative ...